Orchestra BioMed Holdings, Inc. · Brief

Next report

12 days

Nov 12est.Q3 FY26

Expected move

±18.5%implied · report alone

4.827.00

straddle ±22.3%

spot 5.91exp Nov 20ATM strike 5ATM straddle 1.55IV 130%

Oct 30 closereport share · term structure

Expected move

No reported quarters.

Nov 12 report · est.

Bull2 of 4

77managers reporting a position in the latest quarterly filings13F · Jun 30 '26

2 of 21of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

Bear2

17.00%of revenue from the largest disclosed customer Ligand Pharmaceuticals IncorporatedSEC filings

8managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

OBIO report session

No linked exposure.

Oct 29impliedImplied move: ±24.1% into Nov 12 earnings (Oct 29 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.